$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Process for preparing rapidly disintegrating granulates 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
출원번호 US-0015011 (1987-02-17)
우선권정보 SE-0000657 (1986-02-14)
발명자 / 주소
  • Appelgren Curt H. (Kungsbacka SEX) Eskilsson Eva C. (Mlnlycke SEX) Uvdal Jonas P. (Gothenburg SEX)
출원인 / 주소
  • Lejus Medical Aktiebolag (Molndal SEX 03)
인용정보 피인용 횟수 : 94  인용 특허 : 4

초록

The present invention relates to a process for preparing a rapidly disintegrating core granulate containing a pharmaceutically active compound, which granulate is optionally intended to be coated with a release determining coating, as well as such cores, whereby one adds a pharmaceutically active co

대표청구항

A process for the preparation of a rapidly disintegrating core comprising a pharmaceutically active compound, said process comprising adding an emulsifier/tenside having a HLB-value corresponding to the solubility characteristics of the pharmaceutically active compound in a solution or a suspension

이 특허에 인용된 특허 (4)

  1. Behl Charanjit (Bloomfield NJ) Beskid George (Upper Montclair NJ) Shah Navnit (Clifton NJ) Tossounian Jacques (Pine Brook NJ) Unowsky Joel (Livingston NJ), Enteric coated oral dosage form.
  2. Ikegami Yoshihiko (Tokyo JPX) Kurihara Kozo (Tokyo JPX) Ichikawa Izuo (Tokyo JPX) Nakane Hisanori (Tokyo JPX), Method of preparing coated solid preparations.
  3. Bauer Kurt H. (Im Finkeler 4 D-7800 Freiburg 33 DEX) Osterwald Hermann (Blucherstr. 16 D-7800 Freiburg DEX), Process for film-coating a particulate solid, and emulsions for conducting the process.
  4. Kawata Hiroitsu (Saitama JPX) Aruga Masayoshi (Saitama JPX) Ohmura Tadayoshi (Saitama JPX) Sonobe Takashi (Saitama JPX) Yoneya Satoru (Saitama JPX) Sone Chiharu (Chiba JPX), Sustained release pharmaceutical composition of solid medical material.

이 특허를 인용한 특허 (94)

  1. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B., Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  2. Robert R. Whittle ; Frederick D. Sancilio ; Grayson Walker Stowell ; Douglas John Jenkins ; Linda B. Whittall, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  3. Robert R. Whittle ; Frederick D. Sancilio ; Grayson Walker Stowell ; Douglas John Jenkins ; Linda B. Whittall, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  4. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  5. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  6. Ekwuribe Nnochiri ; Ramaswamy Muthukumar ; Rajagopalan Jayanthi Sethuraman, Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same.
  7. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam, Calcitonin drug-oligomer conjugates, and uses thereof.
  8. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam, Calcitonin drug-oligomer conjugates, and uses thereof.
  9. Etinger, Marina Yu; Fedotev, Boris; Koltai, Tamas; Kurgan, Ziv; Malachi, Omer, Candesartan cilexetil polymorphs.
  10. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Cation complexes of insulin compound conjugates, formulation and uses thereof.
  11. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Cation complexes of insulin compound conjugates, formulations and uses thereof.
  12. Asgharnejad Mandana ; Shiromani Prafull K., Compositions for inhibiting platelet aggregation.
  13. Dempski Robert E. (Dresher PA) Scholtz Edward C. (King of Prussia PA) Nibbelink Donald W. (Lansdale PA) Reines Scott A. (New Hope PA), Controlled release combination of carbidopa/levodopa.
  14. Pellikaan, Hubert Clemens; Vermeulen, Pieter Sebastiaan; Bender, Johannes Caspar Mathias Elizabeth; Woerlee, Geert Feye, Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances.
  15. Sugiyama Makoto (Kyoto JPX) Okita Atsuhiko (Otsu JPX) Seki Junzo (Ibaragi JPX), Drug carriers.
  16. Ekwuribe,Nnochiri N.; Ramaswamy,Muthukumar; Rajagopalan,Jayanthi, Drug-oligomer conjugates with polyethylene glycol components.
  17. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Fontana Steven A., Dry blend pharmaceutical formulations.
  18. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Dry blend pharmaceutical formulations.
  19. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B., Dry blend pharmaceutical unit dosage form.
  20. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda D., Dry-blend pharmaceutical formulations.
  21. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson Jr., Wes; Ansari, Aslam M., Enkephalin conjugates.
  22. Venkatesh, Gopi M.; Vishnupad, Krishna S.; Percel, Phillip J., Extended release dosage forms of propranolol hydrochloride.
  23. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker, FT-Raman spectroscopic measurement.
  24. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Pavliv, Leo; Polowy, Karen; Puskas, Monica; Ekwuribe, Nnochiri N., Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof.
  25. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Pavliv, Leo; Polowy, Karen; Puskas, Monica; Ekwuribe, Nnochiri N., Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof.
  26. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  27. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  28. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  29. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Granulated pharmaceutical formulations and methods for making the same.
  30. Ekwuribe Nnochiri Nkem ; Ramaswamy Muthukumar ; Radhakrishnan Balasingam ; Allaudeen HameedSulthan S., Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin.
  31. Benjamin Oshlack ; Mark Chasin, Immediate release tablet cores of insoluble drugs having sustained-release coating.
  32. Oshlack Benjamin ; Chasin Mark, Immediate release tablet cores of insoluble drugs having sustained-release coating.
  33. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann; Ansari,Aslam M.; Odenbaugh,Amy L.; Radhakrishnan,Balasingam, Insulin conjugates for treating diabetes mellitus.
  34. Radhakrishnan,Balasingam; Soltero,Richard; Ekwuribe,Nnochiri N.; Puskas,Monica; Sangal,Diti, Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  35. Soltero,Richard; Radhakrishnan,Balasingam; Ekwuribe,Nnochiri N., Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  36. Ekwuribe,Nnochiri N.; Ramaswamy,Muthukumar; Rajagopalan,Jayanthi, Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin.
  37. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica E.; Ekwuribe, Nnochiri N., Insulin-oligomer conjugates, formulations and uses thereof.
  38. Radhakrishnan, Balasingam; Aggarwal, Diti; Ferro, Michelle; James, Kenneth D.; Malkar, Navdeep B.; Miller, Mark A.; Puskas, Monica; Ekwuribe, Nnochiri N., Insulin-oligomer conjugates, formulations and uses thereof.
  39. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  40. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  41. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  42. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan, Method of improving bioavailability.
  43. Maruyama Naosuke,JPX ; Nishiyama Yuichi,JPX ; Kokubo Hiroyasu,JPX, Method of manufacturing a solid preparation coated with non-solvent coating.
  44. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson Jr., Wes; Ansari, Adam M., Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity.
  45. Ekwuribe, Nnochiri N.; Rhadakrishnan, Balasingam; Price, Christopher H.; Anderson, Jr., Wes; Ansari, Aslam M., Methods for delivery therapeutic compounds across the blood-brain barrier.
  46. Braude, Viviana; Aronhime, Judith; Shabat, Shalom, Methods for the production of sildenafil base and citrate salt.
  47. Ekwuribe, Nnochiri N.; Radhakrishnan, Balasingam; Price, Christopher H.; Anderson, Jr., Wes; Ansari, Aslam M., Methods of activating a receptor using amphiphilic drug-oligomer conjugates.
  48. Still, James Gordon; Kosutic, Gordana, Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus.
  49. Soltero, Richard; Radhakrishnan, Balasingam; Ekwuribe, Nnochiri N., Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same.
  50. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties.
  51. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann, Methods of treating diabetes mellitus.
  52. Marie J. Bettman ; Phillip J. Percel ; Dan L. Hensley ; Krishna S. Vishnupad ; Gopi M. Venkatesh, Methylphenidate modified release formulations.
  53. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  54. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Odenbaugh,Amy L., Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  55. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  56. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  57. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Radhakrishnan,Balasingam; Odenbaugh,Amy L., Mixtures of insulin drug-oligomer comprising polyalkylene glycol.
  58. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Radhakrishnan, Balasingam; Odenbaugh, Amy L., Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  59. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Radhakrishnan,Balasingam; Odenbaugh,Amy L., Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  60. Chen Chih-Ming ; Chou Joseph ; Kositprapa Unchalee, Omeprazole formulation.
  61. Chen Chih-Ming ; Chou Joseph C. H. ; Weng Timothy, Omeprazole formulation.
  62. Chen Chih-Ming ; Chou Joseph C. H. ; Weng Timothy, Omeprazole formulation.
  63. Chen, Chih-Ming; Chou, Joseph C. H.; Weng, Timothy, Omeprazole formulation.
  64. Chen, Chih-Ming; Chou, Joseph; Kositprapa, Unchalee, Omeprazole formulation.
  65. Chen, Chih-Ming; Chou, Joseph; Kositprapa, Unchalee, Omeprazole formulation.
  66. Khedkar, Anand; Rangappa, Sharath Kumar Mallapura; Subramani, Ramesh; Dave, Nitesh; Radhakrishnan, Devesh; Shankar, Sundaresh; Chivukula, Sudheer; Ramakrishna, Ranjith; Murthy, Shanmugam Thandava; Pai, Harish Venkatraman; Sengupta, Nilanjan; Melarkode, Ramakrishnan; Iyer, Harish, Orally administrable solid pharmaceutical composition and a process thereof.
  67. Venkatesh, Gopi M.; Harmon, Troy M.; Taylor, John, Orally disintegrating tablets of atomoxetine.
  68. MacLaren David D. ; Lefler John R. ; Minish Sharon K., Pharmaceutical composition for combination of piperidinoalkanol-decongestant.
  69. Ortyl Thomas T. ; Skultety Paul F. ; Mitchell Kristen C. ; Phadke Deepak S. ; Attarchi Faraneh ; Pierce Marguerite L. ; Schoeneman Aaron W. ; Schnitz Joseph M., Pharmaceutical composition for piperidinoalkanol compounds.
  70. Ortyl Thomas T. ; Skultety Paul F. ; Mitchell Kristen C. ; Phadke Deepak S. ; Attarchi Faraneh ; Pierce Marguerite L. ; Schoeneman Aaron W. ; Schnitz Joseph M., Pharmaceutical composition for piperidinoalkanol compounds.
  71. Ortyl Thomas T. ; Skultety Paul F. ; Mitchell Kristen C. ; Phadke Deepak S. ; Attarchi Faraneh ; Pierce Marquerite L. ; Schoeneman Aaron W. ; Schnitz Joseph M., Pharmaceutical composition for piperidinoalkanol compounds.
  72. Ortyl, Thomas T; Skultety, Paul F; Mitchell, Kristen C; Phadke, Deepak S; Attarchi, Faraneh; Pierce, Marguerite L; Schoeneman, Aaron W; Schnitz, Joseph M, Pharmaceutical composition for piperidinoalkanol compounds.
  73. Ortyl Thomas T. ; Skultety Paul F. ; Mitchell Kristen C. ; Phadke Deepak S. ; Attarchi Faraneh ; Pierce Marguerite L. ; Schoeneman Aaron W. ; Schnitz Joseph M., Pharmaceutical compositions for piperidinalkanol compounds.
  74. Soltero, Richard; Radhakrishan, Balasingam; Ekwuribe, Nnochiri N.; Rehlaender, Bruce; Hickey, Anthony; Bovet, Li Li, Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith.
  75. Soltero,Richard; Radhakrishan,Balasingam; Ekwuribe,Nnochiri N.; Rehlaender,Bruce; Hickey,Anthony; Bovet,Li Li, Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith.
  76. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan, Pharmaceutical formulations.
  77. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Fontana Steven A., Pharmaceutical unit dosage form.
  78. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan ; Fontana Steven A., Pharmaceutical unit dosage form.
  79. Kilbride ; Jr. Terence K. (Bloomfield Hills MI), Process for rotary fluid bed granulation of riboflavin.
  80. Radhakrishnan, Balasingam; Soltero, Richard; Ekwuribe, Nnochiri N., Proinsulin polypeptide-oligomer conjugates.
  81. Ishimaru Sueaki (Menuma JPX) Ouchi Kiyohisa (Menuma JPX) Takeuchi Kimito (Menuma JPX) Yamada Masaki (Menuma JPX), Readily absorbable drug formulation of NB-818.
  82. Jordan Barth ; Anthony E. Winston ; Norman Usen, Remineralizing-mineralizing oral products containing discrete cationic and anionic agglomerate components and method of use.
  83. Preis Walter (Neustadt DEX) Musel Bernd (Worms DEX) Neugebauer Gunther (Mannheim DEX) Gabel Rolf-Dieter (Schwetzingen DEX), Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance.
  84. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  85. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  86. Percel, Phillip; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed pulsatile drug delivery systems.
  87. Percel,Phillip J.; Vishnupad,Krishna S.; Venkatesh,Gopi M.; Lee,Der Yang, Timed pulsatile drug delivery systems.
  88. Venkatesh, Gopi M., Timed, pulsatile release systems.
  89. Venkatesh, Gopi M., Timed, pulsatile release systems.
  90. Venkatesh, Gopi M., Timed, pulsatile release systems.
  91. Venkatesh, Gopi M., Timed, pulsatile release systems.
  92. Venkatesh, Gopi M., Timed, pulsatile release systems.
  93. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  94. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로